Background: Breast cancer is the most common female malignancy worldwide. The aim of this study was to investigate the influence of surgical procedures and quality-of-care (QoC) on qualityof-life (QoL) among breast cancer survivors who underwent breast-conserving therapy (BCT) or mastectomy, and to identify provider-and patient-related factors pertaining to QoL. Method: In this cross-sectional study, structured-questionnaires were distributed among breast cancer survivors in 19 hospitals. QoL was evaluated using the European Organization for Research and Treatment of Cancer core questionnaire (EORTC QLQ-C30) and the breast cancer specific module (EORTC QLQ-BR23). QoC is indicated by adherence to the core measures stipulated for the treatment of breast cancer. Multiple regression and hierarchical linear modeling were used for multivariate analysis. Results: A total of 544 female survivors of Stage 0-III breast cancer were included, among whom 217 (39.9%) underwent BCT and 327 (60.1%) underwent mastectomy. Surgical modality does not appear to have a notable impact on any QoL domains except body image; i.e. patients who underwent BCT reported better body image (diff = 11.20, P < 0.001), particularly at 1-5 years after the initial treatment. Independent factors including age, education, employment, marital status, income, chemotherapy, duration since treatment, recurrence status, primary hospital accreditation level and location all appear to be correlated to QoL. Conclusion: Patients with breast cancer should be informed of differences in QoL when discussing treatment options. Furthermore, physicians should recognize that the impact of surgical treatment modality on QoL may vary according to patients' sociodemographic and clinical characteristics.
Introduction
Breast cancer is the most common form of cancer and the principal cause of death among women in developing as well as developed nations (1, 2) . In Taiwan, it is the most common cancer among females and the fourth leading cause of cancer-related death. In 2012, 11 305 newly diagnosed cases of female breast cancer were recorded (3) . In 2013, the 5-year survival rate was 87.2% (4) . Increasing incidence and prolonged survival underline the importance of elucidating the quality of care process and the specific outcomes experienced by survivors.
Surgical excision is the primary treatment modality for breast cancer. This approach includes mastectomy and breast-conserving therapy (BCT), followed by various forms of conjunctive radiation, chemotherapy and/or hormone therapy. Numerous studies have demonstrated that the difference in survival between mastectomy and BCT is negligible (5, 6) ; however, the choice of treatment could greatly influence the patient's quality-of-life (QoL) (7) , the effects of which could potentially last for years (8, 9) . Moreover, better QoL could actually lead to longer survival (10, 11) . Most previous studies have reported that the type of breast cancer surgery has no effect on any aspect of QoL except body image and sexual function (11, 12) . Unfortunately, most of those studies focused on the experience of patients in western countries. It is important to extend this research to eastern countries (13) , due to the fact that the incidence is rising rapidly and the effects on QoL may have important cultural overtones (14, 15) . Furthermore, previous findings pertaining to the impact of surgery type on QoL in Taiwan are limited and remain inconclusive (16) (17) (18) .
Process of care refers to the provision and reception of care through interactions between patients and providers. It can be measured using indicators at the organizational and/or individual level (19) , as a means of evaluating the quality of care and identifying potential problems associated with the provision of health care (20) . In the 1999 report 'Ensuring quality cancer care,' the Institute of Medicine (IOM) concluded that many patients with cancer fail to receive state-of-the-art care (21) . Furthermore, despite establishing a large number of quality measures, relatively little work was conducted in the field of breast cancer until 2004 (22, 23) . In Taiwan, since 2005, the Health Promotion Administration of the Ministry of Health and Welfare has been tracking the performance of breast cancer hospitals using a set of breast cancer core measures that focus on pre-treatment, treatment and follow-up (24) . Previous studies have revealed that superior quality-of-care (QoC) can lead to better survival (25) (26) (27) and better QoL (28) . Nonetheless, very little work has been done to elucidate the influence of surgical type and care process quality on QoL in breast cancer.
The aim of this study was to compare the influences of surgery treatment modality and QoC on QoL over various periods of time after the initial treatment, and to identify patient demographics, clinical characteristics and primary hospital characteristics of relevance to QoL.
Patients and methods
This cross-sectional study utilized a structured questionnaire survey. Study participants were drawn from 19 cancer hospitals with care quality certification in Taiwan between January and July 2011. In Taiwan,~80% of cancer patients are treated in hospitals with cancer care quality certification, and 40 hospitals had passed accreditation at the time of the study. The facilities in this study included seven medical centers and 12 regional hospitals; nine of which were located in northern Taiwan, six were located in central Taiwan, and four were located in southern Taiwan. We contacted one breast cancer specialist at each of the participating hospitals and collected data consecutively during his/her outpatient shift in the waiting area of the outpatient department. Female breast cancer survivors over 20 years of age were approached by trained interviewers of the research group or breast cancer staff of the hospital. The data were collected after receiving approval from the ethical review board of National Taiwan University as well as the 19 hospitals, and informed consent was obtained from every patient prior to their participation in the survey.
QoL was measured using two common questionnaires (29) : the European Organization for Research and Treatment of CancerQuality of Life Core Questionnaire (EORTC QLQ-C30) (30) and the Breast Cancer Module (EORTC QLQ-BR23) (31) . The EORTC-QLQ-C30 questionnaire comprises 30 items, including global health, five functional scales and eight symptom scales. The EORTC QLQ-BR23 questionnaire comprises 23 items, including four functional scales and four symptom scales. Global health was rated using a 7-point Likert scale. The other 28 items and the QLQ-BR23 items were rated using a 4-point scale. The time frame was 'during the past week,' except for the sex-related items, which was 'during the past 4 weeks.' The scoring followed the algorithm recommended by EORTC (32) . All scores were transformed linearly, such that the scales ranged from 0 to 100. Higher scores on the functioning scales and lower scores on the symptoms scales indicate better QoL. The Taiwan Chinese version of the EORTC QLQ-C30 (version 3) and EORTC QLQ-BR23 presented good test/retest reliability and high internal consistency (33) . To explore the predictors of overall QoL, we adopted the global health status of QLQ-C30, and calculated four summary scores: (1) functional scale of QLQ-C30, (2) symptom scale of QLQ-C30, (3) functional scale of QLQ-BR23, and (4) symptom scale of QLQ-BR23, as proposed by Hinz et al. (34) . The clinical significance of the QoL score is based on the rationale proposed by Osaba et al. (35) , in which specific differences in score refer to specific effect sizes, as follows: 5-10 (small effect), 10-20 (moderate effect), and >20 (large effect).
QoC was measured using structured questions modified from the Breast Cancer Core Performance Measures (24) for the treatment of breast cancer. We used four measures including the following two pre-treatment measures and two treatment measures: (1) bilateral mammography within a 3-month period prior to surgery; (2) cytological and histological diagnosis prior to surgery; (3) pathology report of tumor-size following surgery; and (4) radiation treatment after BCT for patients with invasive cancer. Patients answered the questions in accordance with their experience while undergoing treatment by physicians and/or hospitals. We then calculated the number of measures each patient achieved and the number of measures each patient was advised to undergo in order to create a self-reported QoC score. The denominator is the total number of applicable measures that the patient was advised to undergo, and the numerator is the number of core measures that the patient actually underwent. The range of self-reported QoC was between 0 and 1, where a higher score indicates better QoC.
Other information gathered in this study fell into four groups: (1) hospital characteristics, including hospital level, location and ownership; (2) sociodemographic factors, including age at diagnosis, educational level, employment, marital status, monthly income, family history of breast cancer and membership in a support group; (3) disease-related factors, including stage of breast cancer at the time of primary diagnosis, recurrence status and duration since initial treatment; and (4) treatment-related factors, including primary surgery type (mastectomy versus BCT), sequence of surgery, chemotherapy, radiotherapy and hormone therapy. Hospital level was classified according to the accreditation status of the facility, the evaluation of which was conducted by the Taiwan Joint Commission on Hospital Accreditation (TJCHA) based on clinical capabilities and bed capacity (36) : medical centers (minimum 500 beds), regional hospitals (minimum 250 beds). Duration since initial treatment was categorized as <1 year, 1-2, 2-5, and ≧5 years.
Before administering the survey, the content validity of the questionnaire was evaluated by three experts, and a pilot study involving 13 breast cancer patients was conducted to test for reliability (Cronbach's alpha: 0.72-0.93).
Quantitative analysis of the questionnaire was conducted using Statistical Analyses System software (SAS Institute, Cary, NC), based on the following statistical methods: (1) Descriptive statistics were used to present hospital/social-demographic/clinical characteristics, QoL scores, and self-reported QoC rates as number, percentage, mean and standard deviation. (2) Univariate analysis was conducted using the independent t-test for continuous variables and the Chi-square test for categorical variables. (3) A generalized linear model was used to compare the QoL of patients who underwent different types of surgery and subsequently survived for various intervals, after controlling for hospital-and patient-related factors. (4) Hierarchical linear regression was used to determine the independent factors affecting global health, functional scores, and symptom scores summed from QLQ-C30 and QLQ-BR23. Table 1 lists the descriptive statistics of the 544 female participants with Stage 0-III breast cancer and the results of univariate analysis comparing the characteristics observed in the mastectomy and BCT groups. The mean age of diagnosis was 52.8 years (SD = 9.4, range: 25-85). A total of 64% of the participants (n = 349) were followed up more than 1 year after the initial treatment, as follows: <1 year (35%), 1-2 years (17%), 2-5 years (28%), ≧5 years (19%). A total of 327 patients (60.1%) underwent mastectomy, and the remaining patients underwent BCT (n = 217, 39.9%). Among our study sample, 497 patients underwent surgery as their first treatment, and 47 received preoperative chemotherapy. Among the 47 patients, 11 underwent BCT and 36 underwent mastectomy after preoperative chemotherapy. Compared with patients that underwent mastectomy, those that underwent BCT tended to be younger, employed, unmarried, with cancer of a lower stage, and received treatment in public facilities. The average self-reported QoC rate was 75.08% (SD = 0.249), and no significant difference in self-reported QoC was observed between the two groups. Table 2 presents the average score of each QoL domain by surgery type. The average scores were as follows: Global health was 64.4 (SD = 21.2); functional scores of QLQ-C30 ranged from 81.2 (cognitive function) to 86.1 (physical function), and functional scores of QLQ-BR23 ranged from 13.6 (sexual function) to 76.9 (body image); symptom scores of QLQ-C30 ranged from 7.4 (diarrhea) to 25.4 (sleep disturbance), and symptom scores of QLQ-BR23 ranged from 15.4 (breast symptoms) to 38.8 (upset by hair loss). The functional scores in the BCT group were higher than the functional scores in the mastectomy group, with the exception of emotional function. The symptom scores in the BCT group were lower than the symptom scores in the mastectomy group, with the exception of breast-related symptoms. We further analyzed the mean score of each QoL domain of BCT and mastectomy groups with surgery as the first treatment. Our results revealed that in most of the domains, the BCT group was slightly better than the mastectomy group, which is consistent with the results obtained when patients with preoperative chemotherapy were not excluded. Table 3 presents the results of ANCOVA comparing the adjusted mean differences in each QoL scale according to surgery types over various durations since initial treatment. After controlling for relevant hospital and patient determinants, surgical modality did not have a significant influence on any aspect of QoL except body image (mean difference = -11.20 P < 0.001). After stratification by durations since initial treatment, the difference of surgery modality in body image remained significant. At 1-2 and 2-5 years after the initial treatment, the mean difference were -19.97 (P = 0.03) and -20.57 (P < 0.001), respectively. At <1 year, mastectomy patients were less likely to have symptoms of nausea (mean difference = -7.1, P = 0.04). After 5 years, no significant differences were observed between BCT and mastectomy groups in any of the QoL domains. Table 4 presents fully adjusted multi-level regression models of global health and functional and symptom summary scores, based on patient and medical factors. In the QLQ-C30, the independent factors significantly associated with better global health included younger age, higher monthly income, and longer duration since treatment. The independent factors significantly associated with higher functional scales included unmarried, longer duration since treatment, no recurrence, being treated in medical centers or in southern Taiwan. Independent factors significantly associated with lower symptoms scales included lower education, longer duration since treatment, and no recurrence. In the QLQ-BR23, the factors significantly associated with better functional scales included BCT, older age, being employed, higher monthly income, not undergoing chemotherapy and longer duration since treatment. The factors significantly associated with lower symptom scales included unmarried, longer duration since treatment, no recurrence, being treated in a medical center or in southern Taiwan. No statistically significant relationship was observed between self-reported QoC and QoL; however, patients with higher QoC were shown to have global health scores that were 5.2 points higher than patients with lower QoC.
Results

Discussion
The Taiwan 2011 cancer registry annual report (37) lists 9882 newly diagnosed breast cancer patients with cancer stage 0 to III, among whom 41.7% underwent BCT and 56.6% underwent mastectomy. A goodness-of-fit-test revealed no significant difference in the distribution of surgical modality among stages between the sample in this study and the general population (P = 0.871). This multicenter study offers original insight into the QoL of Taiwanese breast cancer survivors that have undergone mastectomy or BCT. The overall global health score was close to the regional and international figures from Nepal (52.8) (38) , China (Shanghai) (61.5 ± 10.7) (39), a Taiwanese study from 2003 (62.1 ± 23.4) (33), Jordan (63.7 ± 20.2) (40), and Sweden (65.1 ± 23.1) (41) . Unlike another Taiwanese single-institutional study (17) , we observed no statistically significant difference between the BCT group and mastectomy group with regard to global health score. This may be due to the fact that our study included short-term as well as long-term survivors, and treatment patterns generally have insignificant long-term effects on QoL (42) (43) (44) (45) . Consistent with that research, patients that underwent BCT in the current study were younger, unmarried, and in an early disease stage.
We found that surgical modality does not have a significant effect on any EORTC-QLQ-C30 or QLQ-BR23 domains except body image; i.e. women that underwent BCT reported better body image than those who received mastectomy. The finding is in keeping with previous short-term follow-up studies (38, (46) (47) (48) (49) , longterm follow-up studies (50) (51) (52) (53) and review articles (11, 12) . Following the aggregation of the function and symptom scales into summary scores, surgery type had an effect only on BR23-functional scores (BR23-FS). We found that patients who underwent BCT presented better BR23-FS than did patients who underwent mastectomy. In Taiwan, the proportion of early-stage patients that Continued underwent breast conserving therapy was lower than in western countries, which may be due to a lack of adequate information on which to base treatment decisions, fear of cancer recurrence, or psychosocial burdens associated with the needs for adjuvant radiotherapy after BCT which requires an additional 5 to 6 weeks for delivery (54) . However, radiotherapy after BCT does reduce the risk of local recurrence (55) , and the effects of mastectomy on QoL may endure longer than the effects of several weeks radiotherapy (56) . Our findings revealed that among Taiwanese women with breast cancer, the issue of mastectomy prompts considerable concern with regard to body image. When discussing treatment options, patients should be reassured that BCT is a reasonable choice in the early stages of the disease, based on the fact that BCT and mastectomy are similar in terms of survival rate (6) as well as QoL. According to the Taiwan Medical Care Act (57), surgical consent forms must be confirmed and signed by patients (and/or their legal representative, spouse, relatives, or legally authorized persons) prior to commencing surgical procedures. Despite differences in format among hospitals, the content is similar, including the state of illness, type of surgery, the objective, process, success rate, benefits and possible risks/complications of the proposed procedure as well as alternative options, and risks if the proposed procedure is not taken. In this manner, the patients in this study should have been informed by their physicians and ultimately made treatment decisions by themselves (and/or with their families). Determining whether the information on which they based their choice was adequate, or whether the decision-making process met patient expectations was beyond the scope of this study. Nonetheless, our results are supported by another Taiwanese study that evaluated the influence of surgery type on QoL as well as the effects of the decision-making process on satisfaction with treatment results (16) . That study revealed no differences in the QoL between mastectomy and BCT groups; however, mastectomy patients appeared to be more concerned about their resulting body image and were more likely to be unsatisfied with the treatment results, despite making treatment decisions by themselves. This study showed that the effect of surgery modality on QoL varied with the time elapsed since initial treatment. At <1 year after treatment, mastectomy patients reported less nausea/vomiting symptoms than did BCT patients. It is possible that patients were in the active treatment phase and were therefore still experiencing the adverse effects of postoperative chemotherapy or radiotherapy. In accordance with earlier longitudinal results (50), BCT patients reported being more satisfied with their body image at 1-2 and 2-5 years after treatment, compared with the mastectomy group over the same time frame. No significant differences were observed between the BCT and mastectomy groups regarding satisfaction with body image beyond 5 years after primary treatment, in agreement with previous studies (42) (43) (44) (45) . Perhaps patients in the followup phase had adapted to the changes in their bodies, such that the effects of breast cancer treatment appeared not to affect their QoL. Similar results were found in a previous study in which differences in QoL between breast cancer survivors and population-based controls were shown to decrease over time and 15-year cancer survivors were generally not different from controls (42) . Moreover, our study discovered a number of cases presenting no statistical differences but moderate clinical differences (i.e., mean differences in QoL scores ranging from 10 to 20 points) as follows: at less than 1 year, fewer mastectomy patients reported hair loss; at 1-2 years, mastectomy patients reported higher cognitive functioning while BCT patients reported higher future perspective; at 2-5 years, mastectomy patients reported higher sexual enjoyment but greater annoyance with hair loss; beyond 5 years, BCT patients presented better global health and less hair loss. When discussing treatment options, breast cancer patients should be informed of the potential differences in QoL that could result from the surgical procedure they choose.
Health professionals should be aware of changes in QoL among breast cancer patients at various time points after surgery. We did not observe statistical differences between self-reported QoC and functional or symptoms scales. This may be explained by the fact that our measurement of QoC was used to determine whether health care services in the pre-treatment and treatment phases met existing standards. Most of the patients reported receiving the health care service they required, which means that differences in QoL cannot be attributed to QoC. Nonetheless, a small clinical difference was observed in the global health scores. Women that reported a higher QoC rating had slightly higher global health scores (5.2 points). The correlations are weak; however, the findings are consistent with previous research from other countries (58) (59) (60) which also indicate a link between QoC and QoL. Our findings revealed several factors associated with postoperative QoL. Women treated in medical centers and/or hospitals located in southern Taiwan reported better C30-functionings and fewer BR23-symptoms. The determinants of QoL variation among hospitals will require further elucidation. Patient factors including age, level of education, employment status, income, and marital status were correlated with QoL domains, which is in line with previous studies (9, 38, 41, 46, 61) . Patients with higher income reported better global health and BR23-FS. Younger subgroups (<50 years) reported poorer BR23-FS than did patients aged >60 years, but patients aged 50-60 years reported poorer global health, compared with patients <50 years. This may be due to the fact that younger patients tend to be more concerned about body image (49) . Moreover, the mean age of being diagnosed with breast cancer in Taiwan is 45-55 years. Most women in this period are primary family caregivers, such that they experience greater disruption in their daily lives, work schedules, and financial stability. This may explain why patients with a higher educational level and married patients reported worse QoL (C30-SS; C30-FS and BR23-SS, respectively), whereas employed women reported better BR23-FS. Nonetheless, the differences of QoL scores among these three factors were less than 5 points. Previous studies have emphasized the benefits of social support on QoL (9,38,41); however, we did not observe statistical significant differences in this regard.
Among the clinical and treatment factors, it was observed that patients who experienced recurrence presented worse QoL (C30-FS, C30-SS and BR23-SS), which is in agreement with previous findings (7, 39) . It was also observed that the time that elapsed since the initial treatment was positively correlated with functional scales and negatively correlated with symptom scales, as demonstrated in earlier studies (18, 42) . Previous studies have reported that adjuvant treatment can adversely affect patient QoL (7, 9, 18, 41, 46, (62) (63) (64) . We found that radiotherapy, hormone therapy, and the sequence of surgery appear not to have an impact on global health status, functioning, or symptoms. This may be explained by the relatively long survival interval of the participants in this study. It is possible for cancer survivors to recover from the side effects of these treatment modalities within 1-3 years following the completion of treatment (39) , which would explain why we did not observe any difference in QoL. Nonetheless, we determined that chemotherapy negatively affected QoL with regard to BR23-functioning. This finding echoes the results of a previous study of 4-year survivors, in which it was reported that few differences in psychosocial adjustment depend on surgical choice, whereas long-term impairments including sexual dysfunction, poor body image and psychological distress were encountered in women who had undergone chemotherapy (65) .
Our findings are somewhat limited by the cross-sectional design; i.e. QoL was measured at a single point in time and the investigators were unable to answer questions concerning improvements or declines in QoL over time. We therefore examined changes in QoL by comparing the QoL score of patients at different survival intervals. We attempted to reduce bias by including patients from different hospitals around Taiwan; however, our findings are still limited by a small sample size, which is not necessarily representative of the rest of Taiwan. Even though informed consent is required prior to surgery, the information content and the decision-making process may influence a woman's choices with regard to surgical treatment. Future studies could investigate the decision-making process to better understand this effect on choice of surgery and postoperative QoL. Self-reported data are susceptible to common-method variance (CMV); however, we sought to control for CMV using ex-ante remedies of counterbalancing question order and improving scale items. Future research should use different sources, such as administrative or cancer registry data, to formulate objective quality indicators for the representation of QoC.
Conclusions
In summary, this multicenter study provides evidence that surgery modality does not have a notable impact on any QoL domains expect body image, and this effect varies with the time since initial treatment. Women with higher self-reported QoC were shown to enjoy slightly better global health. Age, education, employment, marital status, income, chemotherapy, duration since treatment, recurrence status, primary hospital accreditation level and location were identified as major factors affecting the postoperative QoL of Taiwanese breast cancer survivors. Women should be informed about the differences in QoL when discussing treatment options. Physicians should recognize that the impact of surgical modality on QoL may vary according to patients' sociodemographic and clinical characteristics. 
